Starting from 2021, the share prices of Novacyt S.A started to decline significantly. From January till July, it has decreased by 863GBP. In the period from April to July, it has not gone above 512.20GBP. On the 20th of July, it opened at 340GBP and closed at 343.10GBP decreasing from the previous close by 12.50GBP. During the day, the price was trading from the lowest price at 340GBP to the highest at 366.28GBP. The average volume exceeds the total volume by 330k GBP. The EPS is 194. Novacyt said that it had added new Coronavirus (COVID-19) tests to its PathFlow lateral flow test (LFT) portfolio. It released an LFT to detect SARS-CoV-2 IgG antibodies at the end of March, and it is working on two other LFTs that will be released later this year.
The PathFlow SARS-CoV-2 SMART IgG is a next-generation LFT that can detect and distinguish IgG antibodies. The test could help physicians better evaluate the impact of vaccination regimens and the degrees of immunity obtained from viral infection. This test will now be available as a CE-IVD in the third quarter of this year, according to the firm.
Paul could do better in his engineering profession where he became a real pro. However, he chose the finance field to find a tranquil environment in his career. Today he creates a good number of great content for our team.